MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Incidental finding of drug-induced movement disorder

G. Avagyan, H. Manvelyan, A. Nazaryan (Yerevan, Armenia)

Meeting: 2016 International Congress

Abstract Number: 910

Keywords: Dopamine receptor antagonists, Drug-induced parkinsonism(DIP)

Session Information

Date: Tuesday, June 21, 2016

Session Title: Drug-induced movement disorders

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: Recognizing a drug-induced movement disorder is critical as only stopping using over the counter dopamine-blocking medications such as metoclopramide can reverse or improve clinical manifestations seen in patients. Metoclopramide, one of the commonly used drugs for stomach and esophageal disorders, for nausea and vomiting, can cause drug-induced parkinsonism in one third of patients using it, ranging from mild symptoms to severe movement disorders.

Background: A 47-year-old man is seen in outpatient clinic for headaches. Headache is the main complain he came to see a doctor, however during history taking the patient complained of general stiffness which he referred as arthritis. He has a several-year history of peptic ulcer disease, gastroesophageal reflux disease and osteoarthritis. Current medications the patient is taking are, metoclopramide, proton pump inhibitor, occasional use of analgesics for arthritis and headaches. Family history is remarkable for peptic ulcer disease, rheumatoid arthritis from the father’s side and diabetes and hypertension from the mother’s side.

Methods: On neurological examination the patient is alert and oriented in time, place and person Speech, language, and mental status are normal. Facial expression lacks mimics; the rest of cranial nerve function is normal. Deep tendon reflexes, muscle strength and sensory examination are without abnormalities. Cerebellar function is intact. The rest of the examination is unremarkable. However, slow movements and rigidity are noted in all extremities.

Results: Diagnosis of metoclopramide induced parkinsonism and tension type headache is established and the patient is advised to stop using metoclopramide, appropriate treatment for headaches is prescribed and the patient is also referred to gastroenterologist for further management of peptic ulcer disease and gastroesophageal reflux disease. The patient was followed for the next 3 months. The patient showed improved Parkinsonian features such as stiffness and rigidity were relieved and facial expression also changed. The patient was surprised that his “arthritis” was relieved.

Conclusions: Diagnosis of drug-induced movement disorders is critical because only stopping the drug may reverse or relieve the symptoms. These conditions can often be misdiagnosed or the symptoms may be misinterpreted by the physicians of other specialties as was in this case stiffness and rigidity interpreted as arthritis.

To cite this abstract in AMA style:

G. Avagyan, H. Manvelyan, A. Nazaryan. Incidental finding of drug-induced movement disorder [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/incidental-finding-of-drug-induced-movement-disorder/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/incidental-finding-of-drug-induced-movement-disorder/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley